Patent ID: 9182383
Filing Date: 2015-11-10
Classification: C12Q,G01N

Abstract:
1. A method of diagnosing an increased risk for the development of pancreatic cancer in a human test subject, said method comprising: a) obtaining a pancreatic cyst fluid specimen from a human test subject; b) analyzing said fluid specimen for the presence of at least three biomarkers for pancreatic carcinoma identifiable in said cyst fluid sample via mass spectroscopy, said presence being indicative of an increased risk for pancreatic cancer, said biomarkers being selected from the group consisting of mucin 1, mucin 2, mucin 5AC, mucin 5B, mucin 6, CEA CAM 1, CEACAM 5, CEACAM 6, CEACAM 7, CEACAM 8, S100-A6, S100-A8, S100-A9 and S100-A11, and c) diagnosing said patient as being at increased risk based on the presence of said markers in said sample.